1 Tancrede S,Bujold E,Giguere Y,et al. Mid-trimester maternal serum AFP and Hcg as markers of preterm and term adverse pregnancy outcomes[J]. J Obstet Gynaecol Can,2015,37(2):111-116. 2 Puntachai P,Wanapirak C,Sirichotiyakul S,et al. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels[J]. Arch Gynecol Obstet,2015,292(1):81-85. 3 Ren F,Hu Y U,Zhou H,et al. Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies[J]. Biomed Rep, 2016,4(4):475-478. 4 Zhang H,Gao Y,F,et al. Non‐invasive prenatal testing for trisomies 21,18 and 13:clinical experience from 146 958 pregnancies[J] . Ultrasound Obstet Gynecol, 2015,45(5):530-538 5 Park S Y,Jang I A,Lee M A,et al. Screening for chromosomal abnormalities using combined test in the first trimester of pregnancy[J]. Obstet Gynecol Sci,2016,59(5):357-366. 6 Iles R K,Shahpari M E,Cuckle H,et al. Direct and rapid mass spectral fingerprinting of maternal urine for the detection of Down syndrome pregnancy[J]. Clin Proteomics,2015,12(1):9. 7 Kevin Spencer. Screening for Down syndrome[J]. Scand J Clin Lab Invest Suppl,2014,74(S244):41-47. 8 Kong X D,Liu N,Xu X J. Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome[J]. Braz J Med Bio Res,2014,47(10):834-841. 9 孙立宁,路兴军,张胜利.孕期母血清AFP和Free-β-hcG及uE3水平对妊娠结局影响[J].社区医学杂志,2018,16(22):1666-1669+1673. 10 虢玉芹.B超联合母体血清AFP、Freeβ-hCG、uE3检测在筛查胎儿中枢神经系统畸形的价值[J].中国计划生育学杂志,2018,26(10):954-957. 11 Masihi S,Barati M,Mohamadjafari R,et al. Assessemnt of nasal bone in first trimester screening for chromosomal abnormalities in Khuzestan[J]. Iran J Reprod Med,2014,12(5):321-326. 12 Xiaoyan Ding,Zi Yang,Yiwei Han,Huan Yu. Correlation of long-chain fatty acid oxidation with oxidative stress and inflammation in pre-eclampsia-like mouse models[J]. Placenta,2015,36(12):1442-1449. 13 Yu H,Yang Z,Ding X,et al. Effects of serum from patients with early-onset pre-eclampsia,HELLP syndrome,and antiphospholipid syndrome on fatty acid oxidation in trophoblast cells[J]. Arch Gynecol Obstet,2015,292(3):559-567. 14 Francisco Alvarez‐Nava,Marisol Soto,et al. Elevated second‐trimester maternal serum β‐human chorionic gonadotropin and amniotic fluid alpha‐fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome[J]. J Obstet Gynaecol Res,2015,41(12):1891-1898. 15 Milosevic-Stevanovic J,Krstic M,Radovic-Janosevic D,et al. Number of decidual natural killer cells.&.macrophages in pre-eclampsia[J]. Indian J Med Res,2016,144(6):823-830. 16 杨岚,石锦平,吴晓,等.早孕期血清PAPP-A检测联合中孕期血清AFP、free β-HCG、uE3检测对DS、ES的筛查效果[J].山东医药,2017,57(35):18-21. 17 Dey P. Role of decidual natural killer cells.&.macrophages in pre-eclampsia[J]. Indian J Med Res,2016,144(6):793-795. 18 Wantania J,Attamimi A,Siswishanto R. A comparison of 2-methoxyestradiol value in women with severe preeclampsia versus normotensive pregnancy[J]. J Clin Diagn Res,2017,16(2):127-132. 19 Tsigas E. Advocacy is essential to supporting women with preeclampsia[J]. Obstet Med,2017,10(1):33-35. 20 Alma L J,Bokslag A,Maas A H,et al. Shared biomarkers between female diastolic heart failure and pre-eclampsia:a systematic review and meta-analysis[J]. ESC Heart Fail,2017,4(2):88-98. 21 Zhao M,Zhu Z,Liu C,et al. Dual-cutoff of sFlt-1/PlGF ratio in the stratification of preeclampsia:a systematic review and metaanalysis[J]. Arch Gynecol Obstet,2017,295(5):1079-1087. |